Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Learn how structured molecular tumor boards, standardized genomic testing, and data pipelines improve targeted treatment selection for cancer patients.

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths from the disease, but experts shared a warning ...

Majority of men in UK will not be offered routine prostate cancer screening - Black men have double the risk of prostate ...